FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

819968004: Afamelanotide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3858380018 Afamelanotide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3858381019 Afamelanotide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3858380018 Afamelanotide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3858381019 Afamelanotide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Afamelanotide (substance) Has disposition Anterior pituitary hormone true Inferred relationship Existential restriction modifier (core metadata concept)
Afamelanotide (substance) Is a Melanocyte stimulating hormone analog true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing afamelanotide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Afamelanotide (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only afamelanotide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Afamelanotide (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing afamelanotide in subcutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Afamelanotide (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only afamelanotide in subcutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Afamelanotide (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Afamelanotide only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Afamelanotide (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing afamelanotide in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Afamelanotide (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start